COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 794: Articles 7931-7940  | Next

Delta-Omicron recombinant SARS-CoV-2 in a transplant patient treated with Sotrovimab
Duerr, R., Dimartino, D., Marier, C., Zappile, P., Wang, G., Plitnick, J., Griesemer, S., Lasek-Nesselquist, E., Dittman, M., Ortigoza, M. B., Prasad, P. J., St. George, K., Heguy, A.
10.1101/2022.04.06.487325 — Posted: 2022-04-06
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein.
Parn, S., Savsani, K., Dakshanamurthy, S.
10.1101/2022.04.05.487186 — Posted: 2022-04-06
Delineating antibody escape from Omicron variants
Gruell, H., Vanshylla, K., Korenkov, M., Tober-Lau, P., Zehner, M., Muenn, F., Janicki, H., Augustin, M., Schommers, P., Sander, L. E., Kurth, F., Kreer, C., Klein, F.
10.1101/2022.04.06.487257 — Posted: 2022-04-06
ViReMaShiny: An Interactive Application for Analysis of Viral Recombination Data
Yeung, J., Routh, A. L.
10.1101/2022.04.06.487215 — Posted: 2022-04-06
Vascular inflammation exposes perivascular cells to SARS-CoV-2 infection
Franca, C. M., Mansoorifar, A., Athirasala, A., Subbiah, R., Tahayeri, A., Bertassoni, L. E.
10.1101/2022.04.05.487240 — Posted: 2022-04-06
Racial/Ethnic, Biomedical, and Sociodemographic Risk Factors for COVID-19 Positivity and Hospitalization in the San Francisco Bay Area
Cho, W. K. T., Hwang, D. G.
10.1101/2022.04.03.22273345 — Posted: 2022-04-06
High incidence of sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant
Huygens, S., Oude Munnink, B., Gharbharan, A., Koopmans, M., Rijnders, B.
10.1101/2022.04.06.22273503 — Posted: 2022-04-06
Delta/ Omicron and Omicron/BA.2 co-infections occurring in Immunocompromised hosts
Leuking, R., Narasimhan, M., Mahimainathan, L., mut, A., Liu, Y., Xing, C., Larsen, C., Clark, A. E., SoRelle, J. A.
10.1101/2022.04.04.22273058 — Posted: 2022-04-06
Pandemic-EBT and grab-and-go school Meals: Costs, reach, and benefits of two approaches to keep children fed during school closures due to COVID-19
Kenney, E. L., Walkinshaw, L. P., Shen, Y., Fleischhacker, S. E., Jones-Smith, J., Bleich, S. N., Krieger, J. W.
10.1101/2022.04.06.22273512 — Posted: 2022-04-06
Serious underlying medical conditions and COVID-19 vaccine hesitancy.
Day, D., Grech, L., Nguyen, M., Bain, N., Kwok, A., Harris, S., Chau, H., Chan, B., Blennerhassett, R., Nott, L., Hamad, N., Tognela, A., Hoffman, D., McCartney, A., Webber, K., Wong, J., Underhill, C., Sillars, B., Winkel, A., Savage, M., Loe, B. S., Freeman, D., Segelov, E., CANVACCS, DIABVACCS, and MSVACCS investigators
10.1101/2022.04.06.22273080 — Posted: 2022-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).